non-opioid-treatment | Media Room

Press Release Sep 2, 2020

Dr. Steven R Fox Dentist to the World's Leaders Discusses Noxious Bad Breath Issues in a Fox 5 New York Interview

Dr. Fox discusses how in this Covid-19 environment volatile sulfur compounds as well as other foul smelling chemicals from our breath hit the mask and we smell our own bad breath in our mask.

Press Release Feb 3, 2020

Akelos Inc.'s PCT International Patent Application, Licensed From Cornell University, Has Published

Press Release Nov 18, 2019

Thomas G. Heffner, Ph.D., Former Pfizer Executive, Joins Akelos Inc. as a Strategic Advisor; Akelos Inc. is a Biotechnology Company Developing Opioid Alternatives

Press Release Nov 13, 2019

Dr. Steven Fox, Icon in Cosmetic Dentistry, Enhances Veneer Technique

Press Release Oct 28, 2019

Dr. Steven Fox, Renowned Cosmetic Dentist on Park Ave. in NYC, Improves Veneer Technique.

Press Release Oct 4, 2019

NIH Grant Awarded to Akelos Collaborator, Funds Work to Develop Non-Opioid Drugs for Neuropathic Pain

Press Release Jun 17, 2019

Roger Frechette, Ph.D., Joins Akelos Inc., as Director of Operations & Business Development

Press Release May 21, 2019

On May 14, 2019 the United States Patent and Trademark Office Issued a Notice of Allowance for the Akelos Trademark

Press Release Apr 29, 2019

Charles B. Berde, MD, PhD, Joins Scientific Advisory Board of Akelos Inc., Biotechnology Company Developing Opioid Alternatives

Press Release Apr 25, 2019

J. David Warren, Ph.D., Joins Scientific Advisory Board of Akelos Inc., Biotechnology Company Developing Opioid Alternatives

Press Release Apr 4, 2019

Senator Thomas Daschle, Former Senate Majority Leader, Appointed Strategic Healthcare Advisor to Akelos Inc., Biotechnology Company Developing Opioid Drug Alternatives

Press Release Mar 27, 2019

Michael Levitt, PhD, a Recipient of the Nobel Prize in Chemistry, Appointed to the Scientific Advisory Board of Akelos Inc., Biotechnology Company Developing Opioid Drug Alternatives

Press Release Mar 11, 2019

Robert Benson, PhD, Appointed Intellectual Property Advisor to Akelos Inc., Biotechnology Company Developing Opioid Drug Alternatives

Press Release Feb 25, 2019

Akelos Inc. Identifies Key Aspects Governing Pharmacophore Interactions With Target Site

Press Release Feb 11, 2019

Akelos Inc. Files Third Patent Application to Develop New Treatment Option for Neuropathic Pain